Tablet Press Increases Output - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Tablet Press Increases Output



The Manesty TPR 500 tablet press from Bosch Packaging Technology features enhancements such as a die table, torque drive and tablet discharge chute, and a human machine interface (HMI).

The TPR 500 is equipped with a new 56-station die table and can produce more than 400,000 tablets per hour. The modular powder feeding system allows for more flexibility with a two-paddle design that can be upgraded to three paddles, depending on product properties and powder characteristics. In addition, the True Flow tablet discharge chute features a pneumatic gate mechanism and an improved take-off angle, helping to reduce product damage and increase output, particularly with shaped or friable tablets.

Connected directly to the turret, the Siemens torque drive achieves high torque at low rpm while saving space in the mechanical area. Turret removal is possible in 10 minutes, while complete product changeover can be achieved in less than one hour. The hygienic design of the Manesty TPR 500, allows production to be separate from the mechanical area, preventing powder contamination in the mechanical zone.

The tablet press was introduced at Interpack 2014.

Source: Bosch Packaging Technology

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here